These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 2361443)

  • 1. Platelet function in nephrotic syndrome patients at the Kenyatta National Hospital.
    Kayima JK; Otieno LS; McLigeyo SO; Kyobe J
    East Afr Med J; 1990 Feb; 67(2):109-12. PubMed ID: 2361443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive study on platelet function, hemostasis, fibrinolysis, peripheral serotonergic system and serum lipids in nephrotic syndrome.
    Małyszko J; Małyszko JS; Pawlak D; Pawlak K; Rydzewski A; Myśliwiec M; Buczko W
    Pol J Pharmacol; 1996; 48(2):191-5. PubMed ID: 9112650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombus formation and platelet-vessel wall interaction in the nephrotic syndrome under flow conditions.
    Zwaginga JJ; Koomans HA; Sixma JJ; Rabelink TJ
    J Clin Invest; 1994 Jan; 93(1):204-11. PubMed ID: 8282789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet aggregation and beta-thromboglobulin levels in nephrotic patients with and without thrombosis.
    Kuhlmann U; Steurer J; Rhyner K; von Felten A; Briner J; Siegenthaler W
    Clin Nephrol; 1981 May; 15(5):229-35. PubMed ID: 6166421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet hyperaggregability in the nephrotic syndrome which is not dependent on arachidonic acid metabolism or on plasma albumin concentration.
    Bennett A; Cameron JS
    Clin Nephrol; 1987 Apr; 27(4):182-8. PubMed ID: 3107859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of platelets in patients with chronic proliferative glomerulonephritis and the nephrotic syndrome.
    Tomura S; Ida T; Kuriyama R; Chida Y; Takeuchi J; Motomiya T; Yamazaki H
    Clin Nephrol; 1982 Jan; 17(1):24-30. PubMed ID: 6459902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surface markers of platelet function in idiopathic nephrotic syndrome in children.
    Tkaczyk M; Baj Z
    Pediatr Nephrol; 2002 Aug; 17(8):673-7. PubMed ID: 12185480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is chronic fatigue syndrome associated with platelet activation?
    Kennedy G; Norris G; Spence V; McLaren M; Belch JJ
    Blood Coagul Fibrinolysis; 2006 Mar; 17(2):89-92. PubMed ID: 16479189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Platelet activation in relapse idiopathic nephrotic syndrome in children].
    Tkaczyk M; Baj Z; Nowicki M
    Pol Merkur Lekarski; 2001 Apr; 10(58):229-32. PubMed ID: 11434163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet function in patients with sickle cell anaemia in Nairobi.
    Maina JM; Aluoch JR
    East Afr Med J; 1996 Sep; 73(9):568-70. PubMed ID: 8991234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Selected parameters of blood platelet function in patients with myeloproliferative syndrome].
    Zuk E
    Ann Acad Med Stetin; 1998; 44():137-54. PubMed ID: 9857536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced affinity for arachidonic acid in platelet-rich plasma from rats with Adriamycin-induced nephrotic syndrome.
    Delaini F; Poggi A; Donati MB
    Thromb Haemost; 1982 Dec; 48(3):260-2. PubMed ID: 6819645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet survival and function in rats with enhanced thrombotic tendency.
    Delaini F; Dejana E; Reyers I; Vicenzi E; De Bellis Vitti G; Poggi A; Donati MB
    Thromb Haemost; 1985 Dec; 54(4):739-43. PubMed ID: 3937273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet hypersensitivity in the nephrotic syndrome.
    Remuzzi G; Marchesi D; Mecca G; de Gaetano G; Silver M
    Proc Eur Dial Transplant Assoc; 1979; 16():487-94. PubMed ID: 548992
    [No Abstract]   [Full Text] [Related]  

  • 15. Increased platelet adhesion under flow conditions is induced by both thalassemic platelets and red blood cells.
    Goldschmidt N; Spectre G; Brill A; Zelig O; Goldfarb A; Rachmilewitz E; Varon D
    Thromb Haemost; 2008 Nov; 100(5):864-70. PubMed ID: 18989531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma and platelet lipid composition and platelet aggregation by arachidonic acid in women on the pill.
    Sadurska B; Tacconi MT; di Minno G; Roncaglioni MC; Pangrazzi J; Donati MB; Bizzi A; Silver MJ
    Thromb Haemost; 1981 Apr; 45(2):150-3. PubMed ID: 7256698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Release of arachidonic acid from human platelets. A key role for the potentiation of platelet aggregability in normal subjects as well as in those with nephrotic syndrome.
    Yoshida N; Aoki N
    Blood; 1978 Nov; 52(5):969-77. PubMed ID: 698401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prothrombotic factors in nephrotic syndrome.
    Saxena R; Batra VV; Singh ND
    Indian J Pathol Microbiol; 2000 Jul; 43(3):319-23. PubMed ID: 11218679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of factors influencing platelet aggregation in patients with chronic glomerulonephritis (CGN)].
    Zdrojewski Z; Raszeja-Specht A; Kustosz J; Skibowska A; Rutkowski B
    Przegl Lek; 1996; 53(5):434-8. PubMed ID: 8754409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spontaneous platelet aggregation in a hereditary giant platelet syndrome (MPS).
    Milton JG; Frojmovic MM; Tang SS; White JG
    Am J Pathol; 1984 Feb; 114(2):336-45. PubMed ID: 6696046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.